Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Clinical trial NCT00957996 · COMPLETED

Trial details

NCT number: NCT00957996
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza Cough Sore Throat Nasal Congestion Myalgia Headache Fatigue

Start date: 2009-10-01
Primary completion: 2010-10-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.